skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Medline Complete【キャンパス外アクセス可】 remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

Citações Citado por
2
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

LYNCH, Thomas J ; BONDARENKO, Igor ; RECK, Martin ; LUFT, Alexander ; SERWATOWSKI, Piotr ; BARLESI, Fabrice ; CHACKO, Raju ; SEBASTIAN, Martin ; NEAL, Joel ; HAOLAN LU ; CUILLEROT, Jean-Marie

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2046-2054 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: Implications for prevention
Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: Implications for prevention
Material Type:
Artigo 		Adicionar ao Meu Espaço

Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: Implications for prevention

Wirtz, A.L. ; Zelaya, C.E. ; Peryshkina, A. ; Latkin, C. ; Mogilnyi, V. ; Galai, N. ; Dyakonov, K. ; Beyrer, C.

AIDS care, 2014-03, Vol.26 (3), p.387-395 [Periódico revisado por pares]

Abingdon: Taylor & Francis

Texto completo disponível

Citações Citado por
4
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

SEQUIST, Lecia V ; YANG, James Chih-Hsin ; SU, Wu-Chou ; BENNOUNA, Jaafar ; KATO, Terufumi ; GORBUNOVA, Vera ; KI HYEONG LEE ; SHAH, Riyaz ; MASSEY, Dan ; ZAZULINA, Victoria ; SHAHIDI, Mehdi ; SCHULER, Martin ; YAMAMOTO, Nobuyuki ; O'BYRNE, Kenneth ; HIRSH, Vera ; MOK, Tony ; GEATER, Sarayut Lucien ; ORLOV, Sergey ; TSAI, Chun-Ming ; BOYER, Michael

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

SOCINSKI, Mark A ; BONDARENKO, Igor ; IGLESIAS, Jose L ; RENSCHLER, Markus F ; KARASEVA, Nina A ; MAKHSON, Anatoly M ; VYNNYCHENKO, Igor ; OKAMOTO, Isamu ; HON, Jeremy K ; HIRSH, Vera ; BHAR, Paul ; HUI ZHANG

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

VAN CUTSEM, Eric ; TABERNERO, Josep ; MCKENDRICK, Joe ; POLIKOFF, Jonathan ; TELLIER, Alexia ; CASTAN, Rémi ; ALLEGRA, Carmen ; LAKOMY, Radek ; PRENEN, Hans ; PRAUSOVA, Jana ; MACARULLA, Teresa ; RUFF, Paul ; HAZEL, Guy A. Van ; MOISEYENKO, Vladimir ; FERRY, David

Journal of clinical oncology, 2012-10, Vol.30 (28), p.3499-3506 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

JOHNSON, Philip J ; SHUKUI QIN ; LIGONG LU ; CHAO, Yee ; BOUCHER, Eveline ; HAN, Kwang-Hyub ; PAIK, Seung-Woon ; ROBLES-AVINA, Jorge ; KUDO, Masatoshi ; LUNAN YAN ; SOBHONSLIDSUK, Abhasnee ; KOMOV, Dmitry ; PARK, Joong-Won ; DECAENS, Thomas ; TAK, Won-Young ; JENG, Long-Bin ; LIU, David ; EZZEDDINE, Rana ; WALTERS, Ian ; CHENG, Ann-Lii ; POON, Ronnie T. P ; RAOUL, Jean-Luc ; PHILIP, Philip A ; HSU, Chih-Hung ; HU, Tsung-Hui ; HEO, Jeong ; JIANMING XU

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

BARLESI, Fabrice ; SCHERPEREEL, Arnaud ; WONG, Elaine K ; PEREZ-MORENO, Pablo ; MITCHELL, Lada ; GROEN, Harry J. M ; RITTMEYER, Achim ; PAZZOLA, Antonio ; FERRER TUR, Neus ; KIM, Joo-Hang ; AHN, Myung-Ju ; AERTS, Joachim G. J. V ; GORBUNOVA, Vera ; VIKSTRÖM, Anders

Journal of clinical oncology, 2013-08, Vol.31 (24), p.3004-3011 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Jacobson, Ira M, Prof ; Dore, Gregory J, Prof ; Foster, Graham R, Prof ; Fried, Michael W, Prof ; Radu, Monica, MD ; Rafalsky, Vladimir V, Prof ; Moroz, Larysa, Prof ; Craxi, Antonio, Prof ; Peeters, Monika, MSc ; Lenz, Oliver, PhD ; Ouwerkerk-Mahadevan, Sivi, PhD ; De La Rosa, Guy, MD ; Kalmeijer, Ronald, MD ; Scott, Jane, PhD ; Sinha, Rekha, PhD ; Beumont-Mauviel, Maria, PhD

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (4.194)

Data de Publicação 

De até
Refinar
  1. Antes de1986  (11)
  2. 1986Até1996  (44)
  3. 1997Até2004  (139)
  4. 2005Até2013  (1.954)
  5. Após 2013  (2.523)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.145)
  2. Japonês  (78)
  3. Serbian  (8)
  4. Georgiano  (3)
  5. Ucraniano  (2)
  6. Búlgaro  (2)
  7. Português  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.